The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II multicenter study of enfortumab vedotin with or without pembrolizumab in rare genitourinary tumors (E-VIRTUE).
 
Elias Chandran
No Relationships to Disclose
 
Nicholas I. Simon
No Relationships to Disclose
 
Daniel da Motta Girardi
Consulting or Advisory Role - BMS Brazil; Ipsen; Janssen Oncology
Speakers' Bureau - Adium Pharma; Bayer; BMS Brazil; Ipsen; Janssen; Merck; Pfizer
Travel, Accommodations, Expenses - Adium Pharma; Ipsen; Pfizer
 
Lisa Ley
No Relationships to Disclose
 
Tzu-fang Wang
No Relationships to Disclose
 
Andre Rashad Kydd
No Relationships to Disclose
 
Saad Omar Atiq
No Relationships to Disclose
 
Salah Boudjadi
No Relationships to Disclose
 
Ian Stukes
No Relationships to Disclose
 
Elizabeth Smith
No Relationships to Disclose
 
Dilara Akbulut
No Relationships to Disclose
 
Scot Anthony Niglio
No Relationships to Disclose
 
Sandeep Gurram
No Relationships to Disclose
 
Marijo Bilusic
Research Funding - Merck (Inst); Surface Oncology (Inst)
 
Seth M. Steinberg
No Relationships to Disclose
 
Andrea B Apolo
No Relationships to Disclose